BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 34215221)

  • 1. Differential gene expression identifies a transcriptional regulatory network involving ER-alpha and PITX1 in invasive epithelial ovarian cancer.
    Li Y; Jaiswal SK; Kaur R; Alsaadi D; Liang X; Drews F; DeLoia JA; Krivak T; Petrykowska HM; Gotea V; Welch L; Elnitski L
    BMC Cancer; 2021 Jul; 21(1):768. PubMed ID: 34215221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The estrogen-regulated transcription factor PITX1 coordinates gene-specific regulation by estrogen receptor-alpha in breast cancer cells.
    Stender JD; Stossi F; Funk CC; Charn TH; Barnett DH; Katzenellenbogen BS
    Mol Endocrinol; 2011 Oct; 25(10):1699-709. PubMed ID: 21868451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative transcriptome analysis of matched primary and distant metastatic ovarian carcinoma.
    Sallinen H; Janhonen S; Pölönen P; Niskanen H; Liu OH; Kivelä A; Hartikainen JM; Anttila M; Heinäniemi M; Ylä-Herttuala S; Kaikkonen MU
    BMC Cancer; 2019 Nov; 19(1):1121. PubMed ID: 31744494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of potential markers for differentiating epithelial ovarian cancer from ovarian low malignant potential tumors through integrated bioinformatics analysis.
    Hao W; Zhao H; Li Z; Li J; Guo J; Chen Q; Gao Y; Ren M; Zhao X; Yue W
    J Ovarian Res; 2021 Mar; 14(1):46. PubMed ID: 33726773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of gene expression in stage I serous tumors identifies critical pathways altered in ovarian cancer.
    Chien J; Fan JB; Bell DA; April C; Klotzle B; Ota T; Lingle WL; Gonzalez Bosquet J; Shridhar V; Hartmann LC
    Gynecol Oncol; 2009 Jul; 114(1):3-11. PubMed ID: 19410283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A systematic review and meta-analysis of hormone receptor expression in low-grade serous ovarian carcinoma.
    Voutsadakis IA
    Eur J Obstet Gynecol Reprod Biol; 2021 Jan; 256():172-178. PubMed ID: 33246201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene expression profiles and pathway enrichment analysis to identification of differentially expressed gene and signaling pathways in epithelial ovarian cancer based on high-throughput RNA-seq data.
    Siavoshi A; Taghizadeh M; Dookhe E; Piran M
    Genomics; 2022 Jan; 114(1):161-170. PubMed ID: 34839022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.
    Jones MR; Peng PC; Coetzee SG; Tyrer J; Reyes ALP; Corona RI; Davis B; Chen S; Dezem F; Seo JH; Kar S; Dareng E; ; Berman BP; Freedman ML; Plummer JT; Lawrenson K; Pharoah P; Hazelett DJ; Gayther SA
    Am J Hum Genet; 2020 Oct; 107(4):622-635. PubMed ID: 32946763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ALDH1A3 contributes to tumorigenesis in high-grade serous ovarian cancer by epigenetic modification.
    Huang J; Tang Y; Li Y; Wei W; Kang F; Tan S; Lin L; Lu X; Wei H; Wang N
    Cell Signal; 2024 Apr; 116():111044. PubMed ID: 38211842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subtype specific elevated expression of hyaluronidase-1 (HYAL-1) in epithelial ovarian cancer.
    Yoffou PH; Edjekouane L; Meunier L; Tremblay A; Provencher DM; Mes-Masson AM; Carmona E
    PLoS One; 2011; 6(6):e20705. PubMed ID: 21695196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of Tumor Heterogeneity in High-Grade Serous Ovarian Cancers.
    Azzalini E; Stanta G; Canzonieri V; Bonin S
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of Hub Genes in High-Grade Serous Ovarian Cancer Using Weighted Gene Co-Expression Network Analysis.
    Wu M; Sun Y; Wu J; Liu G
    Med Sci Monit; 2020 Mar; 26():e922107. PubMed ID: 32180586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel transcriptional network for the androgen receptor in human epididymis epithelial cells.
    Yang R; Browne JA; Eggener SE; Leir SH; Harris A
    Mol Hum Reprod; 2018 Sep; 24(9):433-443. PubMed ID: 30016502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolving population-based statistics for rare epithelial ovarian cancers.
    Matsuo K; Machida H; Matsuzaki S; Grubbs BH; Klar M; Roman LD; Sood AK; Gershenson DM; Wright JD
    Gynecol Oncol; 2020 Apr; 157(1):3-11. PubMed ID: 31954534
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated bioinformatic analysis identifies UBE2Q1 as a potential prognostic marker for high grade serous ovarian cancer.
    Topno R; Singh I; Kumar M; Agarwal P
    BMC Cancer; 2021 Mar; 21(1):220. PubMed ID: 33663405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer].
    Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H
    Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477
    [No Abstract]   [Full Text] [Related]  

  • 19. Global analysis of estrogen receptor beta binding to breast cancer cell genome reveals an extensive interplay with estrogen receptor alpha for target gene regulation.
    Grober OM; Mutarelli M; Giurato G; Ravo M; Cicatiello L; De Filippo MR; Ferraro L; Nassa G; Papa MF; Paris O; Tarallo R; Luo S; Schroth GP; Benes V; Weisz A
    BMC Genomics; 2011 Jan; 12():36. PubMed ID: 21235772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-Cell RNA-Sequencing Atlas Reveals the Tumor Microenvironment of Metastatic High-Grade Serous Ovarian Carcinoma.
    Deng Y; Tan Y; Zhou D; Bai Y; Cao T; Zhong C; Huang W; Ou Y; Guo L; Liu Q; Yin D; Chen L; Luo X; Sun D; Sheng X
    Front Immunol; 2022; 13():923194. PubMed ID: 35935940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.